Internship

Intern

Clinical Supply Planning

Updated on 11/26/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Cambridge, MA, USA

Internship requires on-site presence in Cambridge, MA from January 21 to June 15, 2025.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
PowerPoint/Keynote/Slides
Requirements
  • Current student enrolled in a Bachelors or Masters program in Chemical Engineering, Biochemical Engineering, Bioengineering, Biomolecular Engineering, Chemistry, Biochemistry, Biomedical Engineering, Biophysics, Biostatistics, Biotechnology, Mathematics, Molecular Biology, Pharmaceutical Science, Statistics, or a related field
  • Creative, capable problem-solver
  • Ideal candidate will have some level of proficiency with Excel, Outlook, Word, MS Project, PowerPoint, Smart Sheets
  • High level of attention to detail
Responsibilities
  • Liaise with Clinical Supply Project Managers and Planners to facilitate logistics as required to support the movement of unlabeled drug product
  • Collaborates with CMC, clinical operations, and project management to ensure timing of clinical trial drug needs are met
  • Manage and monitor expiration dating for coordination of expiry extension with CMC
  • Monitor inventory and distribution activities and update forecasting actuals on regular basis
  • Utilize internal forecasting solution to create demand planning for various studies
  • Participate in user acceptance testing (UAT) of forecasting solution and other clinical supply systems as required
  • Contribute to management of demand planning cycle within Clinical Development Organization
  • Manage Temperature Excursions as required to ensure no dosing interruptions
  • Monitor and assist with presentation of KPIs and metrics for demand/supply planning for Clinical Supply Organization
  • Ensures work is done in compliance to relevant SOPs

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?